|

Roflumilast Clinical Trials

3 actively recruiting trials across 1 location

▲ +1 trial since May 2026

Pipeline

Phase 1: 1Phase 2: 1Phase 3: 1

Top Sponsors

  • The University of Texas Health Science Center at San Antonio1
  • Tanta University1
  • Horus University1

Indications

  • Depression1
  • Arthritis1
  • Depressive Disorder, Major1
  • Rheumatoid Arthritis1
  • Diffuse Large B-Cell Lymphoma1

Other2 trials

Effect of Roflumilast and Desloratadine as Add-On Therapy in Patients With Rheumatoid Arthritis
Phase 2
Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients
Phase 3

San Antonio, Texas1 trial

Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)

University Hospital System

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.